Journal
/
Medicine
/
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
JoVE Journal
Medicine
This content is Free Access.
JoVE Journal Medicine
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

English

Automatically Generated

14,363 Views

•

07:40 min

•

March 20, 2021

DOI:

10.3791/60776-v

DOI:
10.3791/60776-v

•

07:40 min
March 20, 2021

•

50 Views
, , , , , , ,
1Translational Medicine, R&D Oncology,AstraZeneca, 2Acerta Pharma, AstraZeneca Group, 3Translational Medicine, R&D Oncology,AstraZeneca

Summary

Automatically generated

This protocol details clinically implementable preparation of high quality PBMC and plasma biosamples at the clinical trial site that can be used for translational biomarker analysis.

Explore More Videos

PBMCPlasmaBlood DrawBiomarker AnalysisClinical TrialPre-analytical VariabilityPharmacokineticsPharmacodynamicsDNA Damage ResponseRadiationCentrifugationCell SeparationBuffy Coat

Read Article

Cite this Article

Marco-Casanova, P., Lukashchuk, N., Lombardi, B., Munugalavadla, V., Frigault, M. M., Harrington, E. A., Barrett, J. C., Pierce, A. J. Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis. J. Vis. Exp. (169), e60776, doi:10.3791/60776 (2021).

Download .ris file

Copy

Share Video

.

Copy